Filamin A (FLNA) modulates chemosensitivity to docetaxel in triple-negative breast cancer through the MAPK/ERK pathway
Authors:
- 7 November 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 37 (4) , 5107-5115
Abstract
A previous RNA interference (RNAi) screen identified filamin A (FLNA) as a potential biomarker to predict chemosensitivity in triple-negative breast cancer (TNBC). However, its ability to modulate chemosensitivity and the underlying mechanism has not been investigated. Genetic manipulation of FLNA expression has been performed in an immortalized noncancerous human mammary epithelial cell line and four TNBC cell lines to investigate its effect on chemosensitivity. Western blot analysis was performed to identify the potential signaling pathway involved. Xenograft mouse model was used to examine the in vivo role of FLNA in modulating chemosensitivity. Overexpression of FLNA conferred chemoresistance to docetaxel in noncancerous human mammary epithelial cells. Knockdown of FLNA sensitized four TNBC cell lines, MDA-MB-231, HCC38, Htb126, and HCC1937 to docetaxel which was reversed by reconstituted FLNA expression. Decreased FLNA expression correlated with decreased activation of ERK. Constitutive activation of ERK2 reversed siFLNA-induced chemosensitization. Inhibition of MEK1 recapitulates the effect of FLNA knockdown. MDA-MB-231 xenograft with FLNA knockdown showed enhanced response to docetaxel compared with control xenograft with increased apoptosis. FLNA can function as a modulator of chemosensitivity to docetaxel in TNBC cells through regulation of the MAPK/ERK pathway both in vitro and in vivo. FLNA may serve as a novel therapeutic target for improvement of chemotherapy efficacy in TNBC.Keywords
Funding Information
- Hebei Medical Development Funding (HMDF-KJJ)
This publication has 28 references indexed in Scilit:
- BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancersBreast Cancer Research, 2015
- Copper is required for oncogenic BRAF signalling and tumorigenesisNature, 2014
- Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in miceMolecular Cancer, 2012
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapiesJournal of Clinical Investigation, 2011
- The Cytoskeleton Protein Filamin-A Is Required for an Efficient Recombinational DNA Double Strand Break RepairCancer Research, 2009
- Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancerOncogene, 2007
- The Triple Negative Paradox: Primary Tumor Chemosensitivity of Breast Cancer SubtypesClinical Cancer Research, 2007
- Ribosomal S6 Kinase (RSK) Regulates Phosphorylation of Filamin A on an Important Regulatory SiteMolecular and Cellular Biology, 2004
- Recovery from DNA Damage-induced G2 Arrest Requires Actin-binding Protein Filamin-A/Actin-binding Protein 280Journal of Biological Chemistry, 2004
- Filamins as integrators of cell mechanics and signallingNature Reviews Molecular Cell Biology, 2001